Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT04439968
NA

Neonatal Brain Oxygenation Study

Sponsor: Stanford University

View on ClinicalTrials.gov

Summary

Implementing target ranges for regional cerebral saturations in extremely preterm infants in the first week of life may improve neurodevelopmental outcomes at 22-26 months corrected age compared to those without targeted cerebral saturations (Csat) using near-infrared spectroscopy (NIRS). Infants will be randomized to a targeted cerebral saturation monitoring group with visible reading of Csat or to a control group with cerebral saturation monitoring, but with blinded Csat measures. Those in the targeted Csat group will follow a treatment guideline to maintain cerebral oxygenation in the target range. The primary outcome is neurodevelopmental outcome as determined by Bayley III cognitive scale score.

Official title: Targeted Cerebral Saturations in Extremely Preterm Infants

Key Details

Gender

All

Age Range

Any - 2 Days

Study Type

INTERVENTIONAL

Enrollment

100

Start Date

2021-08-10

Completion Date

2025-12-31

Last Updated

2024-04-18

Healthy Volunteers

No

Interventions

OTHER

Clinical algorithm

In order to maintain cerebral saturations within targeted range, subjects in the targeted Csat arm will undergo clinical interventions based on clinical algorithm. Interventions may include administration of inotropes, fluid resuscitation, transfusion of blood products, and/or adjustment to respiratory support.

Locations (1)

Lucile Packard Children's Hospital Stanford

Palo Alto, California, United States